Fuelled by innovation, the outlook for the biotech sector remains positive and should be viewed separately from the macro environment, says Peter Hughes.
Demerger set to strengthen balance sheet
Healthcare industry facing moral dilemma
Managers fear repeat of dotcom bubble
With great power comes great responsibility. As ESG momentum intensifies, the scrutiny over the pharmaceutical sector’s role in society is increasing. How 'pharma' evolves to meet fresh ESG challenges will present challenges and opportunities for the...
Manager critical of Westminster's response
Shareholders lost 16.3% over the past year